<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------
FORM 8-A
FOR REGISTRATION OF CERTAIN
CLASSES OF SECURITIES PURSUANT
TO SECTION 12(b) OR 12(g) OF THE
THE SECURITIES EXCHANGE ACT OF 1934
-----------------------------------------
DURA PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware 95-3645543
----------------------------------- ------------------------------------
(State of incorporation (I.R.S. Employer Identification No.)
or organization)
7475 LUSK BOULEVARD
SAN DIEGO, CA 92121
(Address of principal executive offices) (Zip Code)
<TABLE>
<S> <C>
If this form relates to the registration If this form relates to the registration
of a class of securities pursuant to of a class of securities pursuant to
Section 12(b) of the Exchange Act and is Section 12(g) of the Exchange Act and is
effective pursuant to General effective pursuant to General
Instruction A(c) please check the Instruction A(d) please check the
following box. / / following box. x
</TABLE>
Securities Act registration statement to which this form relates: 333-35512
-------------------
Securities to be registered pursuant to Section 12(b) of the Act:
<TABLE>
<CAPTION>
Title of Each Class Name of Each Exchange on Which
to be so Registered Each Class is to be Registered
------------------- ------------------------------
<S> <C>
Not Applicable Not Applicable
</TABLE>
Securities to be registered pursuant to Section 12(g) of the Act:
Warrants to purchase a fraction of a share of common stock,
par value $.001 per share
--------------------------------------------------------
(Title of class)
<PAGE>
INFORMATION REQUIRED IN REGISTRATION STATEMENT
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
This registration statement relates to certain warrants ("Warrants") of
Dura Pharmaceuticals, Inc. ("Dura"). A description of such Warrants is
contained under the heading "Description of the Warrants" in that
certain registration statement on Form S-4 (Registration No. 333-35512)
filed with the Securities and Exchange Commission by Dura on April 25,
2000 as amended (the "Registration Statement"), which Registration
Statement is hereby incorporated by reference. In addition, the form of
prospectus filed by the registrant pursuant to Rule 424(b) promulgated
under the Securities Act of 1933, as amended, shall be deemed to be
incorporated by reference into the Registration Statement.
ITEM 2. EXHIBITS.
1. Form of Warrant Agreement, including Form of Warrant, filed as
Exhibit 4.10 to the Registration Statement.
2. Certificate of Incorporation of Dura, filed as Exhibit 3.1 to
the Registration Statement.
3. Dura's Common Stock Certificate, filed as Exhibit 4.1 to the
Registration Statement.
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange
Act of 1934, the registrant has duly caused this Registration Statement to be
signed on its behalf by the undersigned, thereto duly authorized.
DURA PHARMACEUTICALS, INC.
Date: July 28, 2000 By: /s/ Cam L. Garner
------------------------------------
Cam L. Garner,
Chairman and Chief Executive Officer
